ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Interferon-beta producing stem cell-derived immune cell therapy on liver cancer – Science Daily

Continue reading

2017-03-28 Michael Zand NEWS

No longer waiting idly: Parents of patients establishing gene therapy programs – Genetic Literacy Project


Science Daily

Interferon-beta producing stem cell-derived immune cell therapy on liver cancer
Science Daily
Hoping to improve primary liver cancer including HCC and metastatic liver cancer therapies, researchers from Japan began studying induced pluripotent stem (iPS) cell-derived immune cells that produced the protein interferon-? (IFN-β). IFN-β exhibits …

and more »

Continue reading

2017-03-28 Michael Zand NEWS

Charpentier, UC Berkeley, U Vienna to Be Granted European CRISPR Patent – Genetic Engineering & Biotechnology News


Genetic Literacy Project

No longer waiting idly: Parents of patients establishing gene therapy programs
Genetic Literacy Project
In recent years, gene therapies have become safer and better at hitting their intended targets in the body, leading to a handful of remarkable cures in clinical trials. Advocates for rare-disease patients—especially determined parents—are …

Continue reading

2017-03-28 Michael Zand NEWS

Study points to dangers in unproven stem cell treatments in local clinics – Miami’s Community Newspapers

Study points to dangers in unproven stem cell treatments in local clinicsMiami’s Community NewspapersThree South Florida women suffered serious loss of vision soon after receiving stem cell treatments for age-related macular degeneration (AMD) at a Bro… Continue reading

2017-03-28 Michael Zand NEWS

Sharing expert experimental knowledge to expedite design – EurekAlert (press release)

EurekAlert (press release)Sharing expert experimental knowledge to expedite designEurekAlert (press release)When building synthetic biological systems, the number of available biological components and interactions is mind boggling. To make them access… Continue reading

2017-03-28 Michael Zand NEWS

EPO to grant UC, Berkeley CRISPR patent – Life Sciences Intellectual Property Review (subscription)

Herald KSEPO to grant UC, Berkeley CRISPR patentLife Sciences Intellectual Property Review (subscription)The European Patent Office (EPO) has revealed its intention to grant a patent covering the CRISPR gene-editing technology to the University of Cali… Continue reading

2017-03-28 Michael Zand NEWS

Plasticell Collaborates with Singaporean Institutions on Stem Cell Research – Pharmaceutical Technology Magazine (press release) (blog)

Plasticell Collaborates with Singaporean Institutions on Stem Cell ResearchPharmaceutical Technology Magazine (press release) (blog)Plasticell, a biotech company specializing in the development of stem cell technologies and cell-based therapies, has si… Continue reading

2017-03-28 Michael Zand NEWS

Stem Cell Treatment Cures Impotence in Some Prostate Cancer Surgery Patients – Newsmax

NewsmaxStem Cell Treatment Cures Impotence in Some Prostate Cancer Surgery PatientsNewsmaxStem cell treatment helped treat erectile dysfunction in some — but not all — prostate cancer surgery patients, a new study says. It included 21 men who became … Continue reading

2017-03-28 Michael Zand NEWS
  • 1
  • …
  • 1,920
  • 1,921
  • 1,922
  • 1,923
  • 1,924
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Charpentier, UC Berkeley, U Vienna to Be Granted European CRISPR Patent
Genetic Engineering & Biotechnology News
The European Patent Office has announced an “intention to grant a patent” broadly covering CRISPR (clustered regularly interspaced short palindromic repeats) technology to Emmanuelle Charpentier, Ph.D., a director at the Max-Planck Institute in Berlin, …

and more »